Oncoimmunin Inc - MD Montgomery, Gaithersburg 20877

Oncoimmunin Inc entered the industry of Medical Labs in 1994 and has grown to employ 1 to 4 people, generating an annual revenue of $5.000.000 to $9.999.999. The NAICS classifies this business under the code 3254140, which describes it as a Medical Labs. For further clarification, the SIC classifies this business under the code 8071 and described it as a Medical Labs. The business provides service to the B2C market.

To acquire more information, please contact Beverly Packard, President by calling (301) 987-7881 during business hours. You can also write to the business’ Single Location at 207a Perry Parkway # 6, Gaithersburg, Maryland MD 20877. You can also visit the company’s website at phiphilux.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Oncoimmunin Inc
Representative: Beverly Packard, President
Place of Business: 207a Perry Parkway # 6, Gaithersburg, MD 20877
Contact Number: (301) 987-7881
Website: phiphilux.com
Type of Service: Medical Labs
SIC Number: 8071
NAICS Number: 3254140
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 1994
Income/Year: $5.000.000 to $9.999.999
Laborers: 1 to 4
Share This Company:

Oncoimmunin Inc is a company operating from Montgomery, Maryland providing professional Medical Labs and relevant B2C variables. It was founded in 1994 and registered with the SIC code 8071 as Medical Labs, and with the NAICS code 3254140 as Medical Labs.

With a current employee count of 1 to 4, Oncoimmunin Inc has gone to report making $5.000.000 to $9.999.999 per annum on its journey towards growth. This company invites you to contact its representative Beverly Packard, President at (301) 987-7881 for related queries, or to locate its Single Location using the coordinates 39.1408,-77.20941.

The Single Location can also be found at the street address 207a Perry Parkway # 6 in Gaithersburg, Maryland 20877 and can be engaged online through the company website at phiphilux.com, the company Twitter , and Facebook page .